Rachael Swann

Mortality and morbidity of locally acquired hepatitis E in the national Scottish cohort: a multicentre retrospective study

Sebastian Wallace, Rachael Swann, Mhairi Donnelly et al. · Alimentary Pharmacology & Therapeutics · 2020 · 37 citations

Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection

Rachael Swann, Vanessa M. Cowton, Mark W. Robinson et al. · Journal of Virology · 2016 · 27 citations · Full text

Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population‐level analysis

Huan Wang, Rachael Swann, Emmanuel Thomas et al. · Journal of Viral Hepatitis · 2018 · 20 citations · Full text

Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection

Mark W. Robinson, Elihú Aranday-Cortés, Derek Gatherer et al. · Liver International · 2015 · 13 citations · Full text

Abstract OT1-03-12: MANTA: A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer

P. Schmid, Maria do Céu Ferreira, Suparna Dubey et al. · Cancer Research · 2016 · 13 citations

Breast Oncology, Profound Mtorc1 Inhibition, Fulvestrant Alone +17